Keywords: update, lilly, increases, icos, offer, 3b, usa-based

UPDATE: Lilly increases ICOS offer 6% to $2.3B

Article | 22 December 2006

Print This

USA-based drugmaker Eli Lilly says that it made an amendment to its proposed acquisition of US biotechnology firm ICOS. Under ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in